9-5024427-T-A

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004972.4(JAK2):​c.226+2214T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.213 in 151,896 control chromosomes in the GnomAD database, including 4,334 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.21 ( 4334 hom., cov: 31)

Consequence

JAK2
NM_004972.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.653
Variant links:
Genes affected
JAK2 (HGNC:6192): (Janus kinase 2) This gene encodes a non-receptor tyrosine kinase that plays a central role in cytokine and growth factor signalling. The primary isoform of this protein has an N-terminal FERM domain that is required for erythropoietin receptor association, an SH2 domain that binds STAT transcription factors, a pseudokinase domain and a C-terminal tyrosine kinase domain. Cytokine binding induces autophosphorylation and activation of this kinase. This kinase then recruits and phosphorylates signal transducer and activator of transcription (STAT) proteins. Growth factors like TGF-beta 1 also induce phosphorylation and activation of this kinase and translocation of downstream STAT proteins to the nucleus where they influence gene transcription. Mutations in this gene are associated with numerous inflammatory diseases and malignancies. This gene is a downstream target of the pleiotropic cytokine IL6 that is produced by B cells, T cells, dendritic cells and macrophages to produce an immune response or inflammation. Disregulation of the IL6/JAK2/STAT3 signalling pathways produces increased cellular proliferation and myeloproliferative neoplasms of hematopoietic stem cells. A nonsynonymous mutation in the pseudokinase domain of this gene disrupts the domains inhibitory effect and results in constitutive tyrosine phosphorylation activity and hypersensitivity to cytokine signalling. This gene and the IL6/JAK2/STAT3 signalling pathway is a therapeutic target for the treatment of excessive inflammatory responses to viral infections. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.65).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.3 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
JAK2NM_004972.4 linkuse as main transcriptc.226+2214T>A intron_variant ENST00000381652.4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
JAK2ENST00000381652.4 linkuse as main transcriptc.226+2214T>A intron_variant 1 NM_004972.4 P1
JAK2ENST00000636127.1 linkuse as main transcriptc.226+2214T>A intron_variant 5

Frequencies

GnomAD3 genomes
AF:
0.213
AC:
32289
AN:
151778
Hom.:
4339
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0491
Gnomad AMI
AF:
0.276
Gnomad AMR
AF:
0.262
Gnomad ASJ
AF:
0.252
Gnomad EAS
AF:
0.251
Gnomad SAS
AF:
0.312
Gnomad FIN
AF:
0.353
Gnomad MID
AF:
0.203
Gnomad NFE
AF:
0.267
Gnomad OTH
AF:
0.217
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.213
AC:
32278
AN:
151896
Hom.:
4334
Cov.:
31
AF XY:
0.220
AC XY:
16287
AN XY:
74178
show subpopulations
Gnomad4 AFR
AF:
0.0490
Gnomad4 AMR
AF:
0.261
Gnomad4 ASJ
AF:
0.252
Gnomad4 EAS
AF:
0.250
Gnomad4 SAS
AF:
0.313
Gnomad4 FIN
AF:
0.353
Gnomad4 NFE
AF:
0.267
Gnomad4 OTH
AF:
0.216
Alfa
AF:
0.241
Hom.:
635
Bravo
AF:
0.194
Asia WGS
AF:
0.259
AC:
899
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
2.3
DANN
Benign
0.76

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs10974921; hg19: chr9-5024427; API